Pfizer shares are down nearly 9% in the past 3 months and severely lagging the broader market. Watch the video to find out if The Oxford Club’s Marc Lichtenfeld and Carter Worth of Sterne Agee think this stock is going to recover anytime soon.
Talking Numbers – CNBC | This Chart Spells Trouble for Pfizer
Get Wealthy Retirement
in Your Email Inbox
Get access to all of the retirement secrets and income strategies from our experts!
Your email is safe with us. View our privacy policy and newsletter FAQs. All investments carry risk and results are not guaranteed.
In The News
